Orozco-Núñez, Emanuel http://orcid.org/0000-0002-6550-7385
Ojeda-Arroyo, Enai http://orcid.org/0000-0002-7188-593X
Cerecer-Ortiz, Nadia http://orcid.org/0000-0001-5200-7894
Guerrero-López, Carlos M. http://orcid.org/0000-0002-6405-5217
Ramírez-Pérez, Beatriz M. http://orcid.org/0000-0003-0080-4140
Heredia-Pi, Ileana http://orcid.org/0000-0002-9998-9239
Allen-Leigh, Betania http://orcid.org/0000-0003-3200-5917
Feeny, Emma http://orcid.org/0000-0002-9514-2305
Serván-Mori, Edson http://orcid.org/0000-0001-9820-8325
Funding for this research was provided by:
The Mexican Association of Pharmaceutical Research Industries, A. C. (2268/1772/S6-21)
Article History
Received: 27 November 2023
Accepted: 17 February 2024
First Online: 11 April 2024
Declarations
:
: This study was approved by the Research, Biosafety, and Ethics Committees of the National Institute of Public Health in Mexico (ID: CI-507–2022/CB22-173).
: Not applicable.
: The authors declare no competing interests. B.M.R.P., I.H.P. and B.A.L. participated voluntarily as part of a Steering Committee of the research proposal, and they became involved in the analysis and paper preparation.